Email this article Effects of age-related androgen deficiency on clinicopsychological characteristics of patients with ischemic heart disease
- Authors: Kravchenko AY.1, Provotorov VM1, Kravchenko AY.1, Provotorov VM1
-
Affiliations:
- Issue: Vol 80, No 12 (2008)
- Pages: 10-13
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30237
- ID: 30237
Cite item
Full Text
Abstract
Aim. To study prevalence of androgen deficiency and its relations with clinicopsychological disorders in males with ischemic heart disease (IHD).
Material and methods. A total of 87 males aged 31-60 years (58 with stable angina of effort FCII- III, 29 with progressive angina of effort) participated in the study. Clinical symptoms of androgen deficiency, severity of anxiety and depression, quality of life were characterized with scales AMS, HADS, D.M. Aronov and V.P. Zaitsev method (2002), respectively. Left ventricular myocardial mass (LVMM) was calculated according to R.Devereux and N. Reichek formula.
Results. Symptoms of male sexual hormones deficiency were seen in 67.8% examinees. In the age groups 31-40, 41-50, 51-60 years androgenic deficiency was diagnosed in 50, 85.7 and 82.9% patients, respectively. A direct correlation was found between androgenic deficiency and total cholesterol (R = 0.38), prothrombin index (R = 0.39), LVMM index (R = 0.48), severity of depression (R = 0.71), anxiety (R = 0.5) and inverse correlation - between androgenic deficiency and quality of life (R = -0.69).
Conclusion. Young and middle-aged patients with ischemic heart disease have symptoms of androgenic deficiency in 67.8% cases. This fact necessitates screening testing of such patients with AMS questionnaire. Male sex hormones deficiency is associated with high anxiety and depression, while quality of life is subnormal.
Material and methods. A total of 87 males aged 31-60 years (58 with stable angina of effort FCII- III, 29 with progressive angina of effort) participated in the study. Clinical symptoms of androgen deficiency, severity of anxiety and depression, quality of life were characterized with scales AMS, HADS, D.M. Aronov and V.P. Zaitsev method (2002), respectively. Left ventricular myocardial mass (LVMM) was calculated according to R.Devereux and N. Reichek formula.
Results. Symptoms of male sexual hormones deficiency were seen in 67.8% examinees. In the age groups 31-40, 41-50, 51-60 years androgenic deficiency was diagnosed in 50, 85.7 and 82.9% patients, respectively. A direct correlation was found between androgenic deficiency and total cholesterol (R = 0.38), prothrombin index (R = 0.39), LVMM index (R = 0.48), severity of depression (R = 0.71), anxiety (R = 0.5) and inverse correlation - between androgenic deficiency and quality of life (R = -0.69).
Conclusion. Young and middle-aged patients with ischemic heart disease have symptoms of androgenic deficiency in 67.8% cases. This fact necessitates screening testing of such patients with AMS questionnaire. Male sex hormones deficiency is associated with high anxiety and depression, while quality of life is subnormal.
References
- Malkin C. J., Pugh P. J., Jones T. H., Channer K. S. Testosterone for secondary prevention in men with ischaemic heart disease? Quart. J. Med. 2003; 96: 521-529.
- Hulley S., Grady D., Bush T. et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen: Progestin Replacement Study (HERS) Group. J. A. M. A. 1998; 280: 605-613.
- Hak A., Witeman J., de Jong F. et al. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam Study. J. Clin. Endocrinol. Metab. 2002; 87: 3632-3639.
- Невзорова В. А., Настрадин О. В., Родионова Л. В. и др. Содержание половых гормонов в сыворотке крови у здоровых с факторами риска развития ишемической болезни сердца и больных ишемической болезнью сердца молодого и среднего возраста. Тер. арх. 2005; 9: 28-31.
- Heinemann L. A., Zimmermann T., Vermeulen A., Thiel C. A new' Aging Male's Symptoms (AMS) rating scale. Aging Male 1999; 2: 105-114.
- Дедов И. И., Калинченко С. Ю. Возрастной андрогенный дефицит у мужчин. М.: Практическая медицина; 2006.
- Dunbar N., Gruman C., Reisine S. et al. Comparison of two health status measures and their associations with testosterone levels in older men. Aging Male 2001; 4: 1-7.
- Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983; 67: 361-370.
- Аронов Д. М., Зайцев В. П. Методика оценки качества жизни больных с сердечно-сосудистыми заболеваниями. Кардиология. 2002; 5: 92-95.
- Вейн А. М. (ред.) Заболевания вегетативной нервной системы: Руководство для врачей. М.: Медицина; 1991.
- Devereux R., Reichek N. Echocardargraphic assesment of left ventricular mass in man. Circulation 1977; 55: 613-618.
- Gray A., Berlin J., McKinlay J., Longcope C. An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. Clin. Epidemiol. 1991; 44: 671-684.
- Thogerson A. M., Jansson J. H., Boman K. et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998; 98: 2241- 2247.
- Barrett-Connor E. Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 1992; 117: 807-811.
Supplementary files
